本文選題：子宮切口妊娠 + 子宮動(dòng)脈灌注栓塞術(shù)��； 參考：《天津醫(yī)科大學(xué)》2014年碩士論文

【摘要】：目的：比較子宮動(dòng)脈灌注栓塞術(shù)(uterus artery infusion embolization, UAIE),甲氨蝶呤(nnethotrexate, MTX)胎囊局部注射、MTX全身用藥、陰式子宮切口瘢痕妊娠病灶清除術(shù)+子宮肌壁修補(bǔ)術(shù)(Transvaginal Cesarean Scar Pregnancy Debridement Surgery and Myometrium Neoplasty, TCSPDS-MN)治療子宮切口妊娠(Cesarean Scar Pregnancy, C SP)的臨床效果,探討不同臨床處理方案的優(yōu)缺點(diǎn),為子宮切口妊娠的臨床治療提供依據(jù)。 方法：對(duì)2009年9月至2013年12月天津市天和醫(yī)院(現(xiàn)天津醫(yī)院)和2010年10月至2013年12月天津市中心婦產(chǎn)科醫(yī)院的子宮切口妊娠352例進(jìn)行回顧性分析,其中UAIE138例,MTX胎囊局部注射83例,MTX全身用藥66例,陰式子宮切口瘢痕妊娠病灶清除術(shù)+子宮肌壁修補(bǔ)術(shù)65例。全面收集上述四組患者的臨床病例資料,分析比較同時(shí)行清宮術(shù)者的術(shù)中出血量、手術(shù)時(shí)間、住院時(shí)間、住院費(fèi)用、并發(fā)癥、術(shù)后陰道出血時(shí)間、術(shù)后β-HCG下降情況,治療成功率,并遠(yuǎn)期隨訪UAIE組術(shù)后及全身MTX組月經(jīng)復(fù)潮時(shí)間、術(shù)后3、6個(gè)月雌二醇(E2)、促卵泡生成素(FSH)水平、卵巢大小等指標(biāo),評(píng)價(jià)子宮動(dòng)脈栓灌注塞術(shù)對(duì)于卵巢功能的影響。 結(jié)果： 1.陰式手術(shù)組術(shù)后陰道出血時(shí)間及住院時(shí)間最短,術(shù)后血β-HCG下降最明顯,其次是UAIE組,全身MTX組最慢(F=42.89,P0.001)。 2. UAIE組手術(shù)時(shí)間及術(shù)中出血量明顯少于其它三組,其次是陰式手術(shù)(F=20.42,P0.001)。陰式手術(shù)時(shí)間長(zhǎng)于局部MTX組及UAIE組(F=41.75,P0.001)。 3.住院費(fèi)用UAIE最高(平均13612±2642元),陰式手術(shù)其次,全身MTX組及局部MTX組費(fèi)用無(wú)明顯差異(P0.05)。 4.四組治療方案中陰式手術(shù)組成功率最高(成功率：87.7%),全身MTX治療最低(成功率為54.5%, F=0.12,P=0.73)；且全身MTX治療的副反應(yīng)最大。 結(jié)論： 1.子宮動(dòng)脈灌注栓塞術(shù)后行清宮術(shù)能充分阻斷子宮動(dòng)脈血流,局部MTX濃度高,大大降低術(shù)中及術(shù)后大出血的風(fēng)險(xiǎn)性,并且保留子宮完整性,對(duì)卵巢功能無(wú)明顯影響,仍是目前子宮切口妊娠的首選治療方法。 2.子宮切口瘢痕妊娠病灶清除術(shù)+子宮肌壁修補(bǔ)術(shù)作為一種全新的微創(chuàng)CSP治療方法,具有一次完全清除病灶、保留患者生育功能、住院時(shí)間短、恢復(fù)快、術(shù)后陰道出血時(shí)間短,血β-HCG下降快等優(yōu)勢(shì),日益受到臨床重視,應(yīng)用日益廣泛。 3.MTX超聲引導(dǎo)下胎囊局部注射治療,毒副反應(yīng)明顯低于全身用藥組,住院費(fèi)用低,對(duì)儀器設(shè)備和醫(yī)生手術(shù)技能要求低,易操作,但具有住院時(shí)間長(zhǎng)、血β-HCG下降緩慢、陰道出血時(shí)間長(zhǎng)等缺點(diǎn),但對(duì)于低收入人群和偏遠(yuǎn)地區(qū)不失為一種良好選擇。 4.MTX全身用藥毒副反應(yīng)相對(duì)較多,成功率低,且住院時(shí)間長(zhǎng),陰道出血時(shí)間長(zhǎng)、血β-HCG下降緩慢,目前此種治療方法不作為治療CSP的常規(guī)方法。
[Abstract]:Objective: to compare the systemic administration of intrauterine arterial infusion embolization (artery infusion embolization,) with intrauterine injection of artery infusion embolization, methotrexate (MTX) into fetal sac. Clinical effect of Transvaginal Cesarean Scar Pregnancy Debridement Surgery and Myometrium Neoplasty, TCSPDS-MNs in the treatment of pregnancy Cesarean Scar Pregnancy, C SP) of uterine incision, the advantages and disadvantages of different clinical treatments were discussed. To provide the basis for the clinical treatment of uterine incision pregnancy. Methods: from September 2009 to December 2013, 352 cases of uterine incision pregnancy in Tianjin Tianhe Hospital (now Tianjin Hospital) and Tianjin Central Gynecology and Obstetrics Hospital from October 2010 to December 2013 were retrospectively analyzed. Among them, 66 cases were treated with UAIE138 and 66 cases were treated with MTX by local injection of fetal sac, 65 cases were treated with uterine muscle wall repair. The clinical data of the four groups were collected, and the blood loss, operation time, hospitalization cost, complications, vaginal bleeding time, and the decrease of 尾 -HCG were analyzed and compared. The success rate of treatment, and long-term follow-up of UAIE group and systemic MTX group menstrual resuscitation time, estradiol E _ 2, follicle stimulating hormone (FSH) level, ovarian size and other indicators, to evaluate the impact of uterine artery embolization on ovarian function. Results: 1. The vaginal bleeding time and hospitalization time were the shortest in the vaginal operation group, and the decrease of serum 尾 -HCG was the most obvious, followed by the UAIE group, and the slowest FV 42.89 渭 m P 0.001 in the systemic MTX group. 2. The time of operation and the amount of intraoperative bleeding in UAIE group were significantly less than those in other three groups. The time of negative operation was longer than that of local MTX group and UAIE group. 3. The cost of UAIE was the highest (mean 13612 鹵2642 yuan) in hospitalization, followed by vaginal operation. There was no significant difference between systemic MTX group and local MTX group (P 0.05). 4. In the four groups, the success rate of negative operation group was the highest (success rate: 87.7%), and that of systemic MTX treatment was the lowest (the success rate was 54.5%, FG 0.12 P < 0.73%), and the side effect of systemic MTX treatment was the largest. Conclusion: 1. Uterine artery blood flow can be blocked by uterine artery infusion embolization, local MTX concentration is high, the risk of massive bleeding during and after operation is greatly reduced, uterine integrity is preserved, and ovarian function is not significantly affected. It is still the first choice of treatment for uterine incision pregnancy. 2. Repair of uterine muscle wall as a new minimally invasive CSP method for uterine incision scar pregnancy focus debridement has the advantages of complete clearance of the lesion, retention of the patient's fertility function, short hospitalization time, rapid recovery, and short postoperative vaginal bleeding time. Blood 尾-HCG has been paid more and more attention and widely used because of its rapid decline. Under the guidance of 3.MTX ultrasound, the side effect of local injection of fetal sac was obviously lower than that of the whole body medication group, the cost of hospitalization was low, the requirement of instrument and medical operation skill was low, the operation skill was easy to operate, but the hospitalization time was long, and the blood 尾 -HCG decreased slowly. Long vaginal bleeding is a good choice for low-income people and remote areas. There are relatively many side effects, low success rate, long hospital stay, long vaginal bleeding time and slow decrease of blood 尾 -HCG in 4.MTX. At present, this treatment method is not a routine method for the treatment of CSP.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R713.8

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 周曉;嚴(yán)園;鄢春暉;郭春燕;廖渝;莫紹玲;岳衛(wèi)東;;UAE對(duì)女性生殖內(nèi)分泌影響的臨床研究[J];重慶醫(yī)學(xué);2008年23期

2 歐陽(yáng)欣;周新春;康友根;莫淑珍;;子宮動(dòng)脈栓塞治療5例剖宮產(chǎn)后子宮切口妊娠[J];重慶醫(yī)學(xué);2010年17期

3 張立華;楊瓊;李帥;劉劍羽;;剖宮產(chǎn)切口妊娠的MRI診斷[J];放射學(xué)實(shí)踐;2013年01期

4 張磊;顧偉瑾;萬(wàn)軍;紀(jì)莉華;王海云;王穎;季芳;陳慶;;氨甲蝶呤與氟尿嘧啶在介入治療剖宮產(chǎn)后子宮切口妊娠中的療效對(duì)比[J];介入放射學(xué)雜志;2012年04期

5 鄧?guó)P蓮;姜振東;李銳;馮玉潔;郭燕麗;鐘華;段靈敏;;超聲對(duì)子宮切口妊娠的診斷價(jià)值[J];臨床超聲醫(yī)學(xué)雜志;2012年08期

6 蔣小平;陸曉蘭;;剖宮產(chǎn)后子宮切口妊娠3例診治分析[J];中國(guó)臨床醫(yī)學(xué);2013年06期

7 范敏;溫娜;李彥;;子宮切除對(duì)卵巢功能影響的臨床研究[J];四川醫(yī)學(xué);2010年01期

8 胡沁松,郭曼,鐘粵明,陳文忠,向彪;介入治療子宮腺肌病的臨床價(jià)值[J];實(shí)用放射學(xué)雜志;2004年07期

9 車榮華;;剖宮產(chǎn)術(shù)后子宮瘢痕處妊娠7例臨床分析[J];中國(guó)醫(yī)師進(jìn)修雜志;2006年03期

10 李莉;李永強(qiáng);;剖宮產(chǎn)術(shù)后子宮切口瘢痕妊娠的診治新進(jìn)展[J];醫(yī)學(xué)綜述;2012年09期

，

本文編號(hào)：1900950